Hematology NewsFIRST trial analysis shows more benefit for lenalidomideFebruary 12, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsThree-drug combo delivers PFS for myeloma in OPTIMISMM trialFebruary 6, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsASCO expands recommendations on bone-modifying agents in myelomaFebruary 5, 2018Multiple Myeloma
Hematology NewsReal-world study makes case for continuous treatment in multiple myelomaJanuary 31, 2018Multiple Myeloma
Hematology TimesPhototherapeutic technology could fight MM, other cancersJanuary 30, 2018Multiple Myeloma
Hematology TimesTreatment costs threaten cancer program growthJanuary 26, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology NewsGene therapy moves from promise to realityJanuary 25, 2018Bleeding DisordersMultiple MyelomaImmunotherapy
Hematology NewsFDA grants priority review to multiple myeloma treatmentJanuary 24, 2018Multiple Myeloma
Hematology TimesBright light therapy improves sleep in cancer survivorsJanuary 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
